One limitation of analyse of Sheba 2.0 in regards to FTO was the inability to determine what drug had the impact. What makes this different if there will be multiple combinations? This also goes into question CP / VO2peak.
*apologies for shirt hand. On the run.
- Forums
- ASX - By Stock
- RAC
- Ann: Updated Strategy and Investor Presentation
Ann: Updated Strategy and Investor Presentation, page-441
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.44 |
Change
0.040(2.86%) |
Mkt cap ! $245.3M |
Open | High | Low | Value | Volume |
$1.45 | $1.49 | $1.41 | $101.7K | 69.88K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9216 | $1.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.47 | 7767 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9216 | 1.440 |
1 | 1314 | 1.435 |
1 | 10000 | 1.420 |
1 | 4000 | 1.410 |
1 | 711 | 1.405 |
Price($) | Vol. | No. |
---|---|---|
1.465 | 7767 | 2 |
1.480 | 3000 | 1 |
1.510 | 687 | 1 |
1.545 | 2040 | 1 |
1.550 | 5000 | 1 |
Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |